Along this line is the observation that low levels of tumor methylation were strongly associated with the presence of various immune cell subsets, including CD4+ regulatory T cells, and lymphocyte infiltration, across different cancer types such as breast cancer, head and neck tumors and lung adenocarcinoma [44]. This evidence concerns the gene CD4 and breast carcinoma.